| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.42 | 3e-14 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.39 | 5e-13 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-12 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.28 | 2e-11 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.24 | 5e-08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.24 | 5e-08 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-07 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-06 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |